C-C motif chemokine 5
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 6 PDB declaration: hexameric(6) Consistent with protein copy count | Chain A; UniProt 27–91 Chain B; UniProt 27–91 Chain C; UniProt 27–91 Chain D; UniProt 27–91 Chain E; UniProt 27–91 Chain F; UniProt 27–91 | Fragment:unp residues 27-91 | SO4 SULFATE ION × 11 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 7.5;303.15 K;0.1 M Tris, 1.8 M Ammonium sulfate | Resolution 3.09 Å R-free 0.258 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 5CMD | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1B3A TOTAL CHEMICAL SYNTHESIS AND HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE POTENT ANTI-HIV PROTEIN AOP-RANTES Deposited 1998-12-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
10–76(67 aa)
|
Not recorded | SO4 SULFATE ION × 3 AOP PENTYLOXYAMINO-ACETALDEHYDE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;pH 4.6
|
Resolution 1.60 Å R-free 0.241 |
| 1B3A TOTAL CHEMICAL SYNTHESIS AND HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE POTENT ANTI-HIV PROTEIN AOP-RANTES Deposited 1998-12-07 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
10–76(67 aa)
|
Not recorded | SO4 SULFATE ION × 1 AOP PENTYLOXYAMINO-ACETALDEHYDE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;pH 4.6
|
Resolution 1.60 Å R-free 0.241 |
| 1EQT MET-RANTES Deposited 2000-04-06 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
25–91(67 aa)
Chain B
25–91(67 aa)
|
Not recorded | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;295 K;PEG 35000, ammonium sulfate, sodium succinate, MES, sodium acetate, ethanol, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295.0K
|
Resolution 1.60 Å R-free 0.251 |
| 1HRJ HUMAN RANTES, NMR, 13 STRUCTURES Deposited 1995-08-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
|
Not recorded | No recorded non-water small molecule | SOLUTION NMR mmCIF provides none of the parsed conditions | Resolution not provided |
| 1RTN PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES, A CHEMOKINE OF THE CC TYPE Deposited 1995-02-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
|
Not recorded | No recorded non-water small molecule | SOLUTION NMR mmCIF provides none of the parsed conditions | Resolution not provided |
| 1RTO PROTON NMR ASSIGNMENTS AND SOLUTION CONFORMATION OF RANTES, A CHEMOKINE OF THE CC TYPE Deposited 1995-02-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
|
Not recorded | No recorded non-water small molecule | SOLUTION NMR mmCIF provides none of the parsed conditions | Resolution not provided |
| 1U4L human RANTES complexed to heparin-derived disaccharide I-S Deposited 2004-07-26 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
|
Not recorded | ACY ACETIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;15% (w/v) PEG 400, 100mM acetate buffer, 1mM Heparin Disaccharide I-S, 10% (w/v) glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.00 Å R-free 0.255 |
| 1U4M human RANTES complexed to heparin-derived disaccharide III-S Deposited 2004-07-26 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
|
Not recorded | ACY ACETIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;15% (w/v) PEG 400, 100mM acetate buffer, 1mM Heparin Disaccharide III-S, 10% (w/v) glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.00 Å R-free 0.252 |
| 1U4P Crystal Structure of human RANTES mutant K45E Deposited 2004-07-26 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
|
Mutation:K45E Mutation:K45E | ACY ACETIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;20% PEG 400, 100mM acetate buffer, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.70 Å R-free 0.254 |
| 1U4R Crystal Structure of human RANTES mutant 44-AANA-47 Deposited 2004-07-26 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
|
Mutation:R44A, K45A, R47A Mutation:R44A, K45A, R47A | SO4 SULFATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;25% PEG 400, 100mM acetate buffer, 200mM (NH4)2SO4, 10% (v/v) glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.20 Å R-free 0.306 |
| 1U4R Crystal Structure of human RANTES mutant 44-AANA-47 Deposited 2004-07-26 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain C
24–91(68 aa)
Chain D
24–91(68 aa)
|
Mutation:R44A, K45A, R47A Mutation:R44A, K45A, R47A | SO4 SULFATE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;293 K;25% PEG 400, 100mM acetate buffer, 200mM (NH4)2SO4, 10% (v/v) glycerol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.20 Å R-free 0.306 |
| 2L9H Oligomeric Structure of the Chemokine CCL5/RANTES from NMR, MS, and SAXS Data Deposited 2011-02-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
Chain C
24–91(68 aa)
Chain D
24–91(68 aa)
|
Not recorded | No recorded non-water small molecule |
Experimental method not declared
NMR measurement conditions
pH 4.4;297 K;Ionic strength (raw mmCIF value) 0.05;Pressure ambient
NMR sample composition
1 mM [U-100% 15N] ccl5, 50 mM sodium acetate, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1 mM [U-100% 15N] ccl5, 50 mM sodium acetate, 5 % polyacrylamide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 2VXW Structural and Functional Studies of the Potent Anti-HIV Chemokine Variant P2-RANTES Deposited 2008-07-12 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain A
33–91(59 aa)
Fragment:CHEMOKINE, RESIDUES 33-91
Chain B
33–91(59 aa)
Fragment:CHEMOKINE, RESIDUES 33-91
Chain C
33–91(59 aa)
Fragment:CHEMOKINE, RESIDUES 33-91
Chain D
33–91(59 aa)
Fragment:CHEMOKINE, RESIDUES 33-91
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.5;pH 5.5
|
Resolution 1.70 Å R-free 0.248 |
| 5COY Crystal structure of CC chemokine 5 (CCL5) Deposited 2015-07-20 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
27–91(65 aa)
Chain B
27–91(65 aa)
|
Not recorded | PO4 PHOSPHATE ION × 2 PEG DI(HYDROXYETHYL)ETHER × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291.15 K;0.2 M Potassium phosphate monobasic, 20% w/v Polyethylene glycol 3,350
|
Resolution 1.44 Å R-free 0.192 |
| 5DNF Crystal structure of CC chemokine 5 (CCL5) oligomer in complex with heparin Deposited 2015-09-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Homooligomer;Protein × 9 PDB declaration: nonameric |
Chain A
27–91(65 aa)
Fragment:UNP residues 27-91
Chain B
27–91(65 aa)
Fragment:UNP residues 27-91
Chain C
27–91(65 aa)
Fragment:UNP residues 27-91
Chain D
27–91(65 aa)
Fragment:UNP residues 27-91
Chain E
27–91(65 aa)
Fragment:UNP residues 27-91
Chain F
27–91(65 aa)
Fragment:UNP residues 27-91
Chain G
27–91(65 aa)
Fragment:UNP residues 27-91
Chain H
27–91(65 aa)
Fragment:UNP residues 27-91
Chain I
27–91(65 aa)
Fragment:UNP residues 27-91
|
Mutation:S4TNR Mutation:S4TNR Mutation:S4TNR Mutation:S4TNR Mutation:S4TNR Mutation:S4TNR Mutation:S4TNR Mutation:S4TNR Mutation:S4TNR | GLA alpha-D-galactopyranose × 6 BGC beta-D-glucopyranose × 5 SO4 SULFATE ION × 5 CL CHLORIDE ION × 20 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;303.15 K;0.1M Tris, pH 7.5; 1.8 M (NH4)2SO4
|
Resolution 2.55 Å R-free 0.234 |
| 5L2U Oligomer crystal structure of CC chemokine 5 (CCL5) Deposited 2016-08-02 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
27–91(65 aa)
Fragment:UNP residues 27-91
Chain B
27–91(65 aa)
Fragment:UNP residues 27-91
Chain C
27–91(65 aa)
Fragment:UNP residues 27-91
Chain D
27–91(65 aa)
Fragment:UNP residues 27-91
Chain E
27–91(65 aa)
Fragment:UNP residues 27-91
Chain F
27–91(65 aa)
Fragment:UNP residues 27-91
|
Not recorded | EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 CL CHLORIDE ION × 2 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;303.15 K;0.1 HEPES, 300 mM NaCl, 3.5% 2-propanol
|
Resolution 2.28 Å R-free 0.209 |
| 5L2U Oligomer crystal structure of CC chemokine 5 (CCL5) Deposited 2016-08-02 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain G
27–91(65 aa)
Fragment:UNP residues 27-91
Chain H
27–91(65 aa)
Fragment:UNP residues 27-91
Chain I
27–91(65 aa)
Fragment:UNP residues 27-91
|
Not recorded | EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.8;303.15 K;0.1 HEPES, 300 mM NaCl, 3.5% 2-propanol
|
Resolution 2.28 Å R-free 0.209 |
| 5UIW Crystal Structure of CC Chemokine Receptor 5 (CCR5) in complex with high potency HIV entry inhibitor 5P7-CCL5 Deposited 2017-01-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
33–91(59 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | ZN ZINC ION × 1 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 6 OLA OLEIC ACID × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6.3;295.5 K;29% (v/v) PEG 400, 120 mM lithium citrate, 1.2% (w/v) 1,5-Diaminopentane dihydrochloride, 100 mM 2-(N-morpholino)ethanesulfonic acid
|
Resolution 2.20 Å R-free 0.250 |
| 6AEZ Crystal structure of human CCL5 trimer Deposited 2018-08-07 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
Chain C
24–91(68 aa)
|
Mutation:E67S Mutation:E67S | SO4 SULFATE ION × 12 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;283 K;0.2M ammonium sulfate, 0.1M BIS-TRIS pH 5, 16% (w/v) polyethylene glycol 3350
|
Resolution 1.63 Å R-free 0.228 |
| 6C6D 20mer crystal structure of CC chemokine 5 (CCL5) Deposited 2018-01-18 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 20 PDB declaration: eicosameric |
Chain A
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain B
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain C
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain D
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain E
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain F
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain G
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain H
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain I
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain J
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain K
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain L
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain M
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain N
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain O
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain P
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain Q
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain R
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain S
27–91(65 aa)
Fragment:UNP Residues 27-91
Chain T
27–91(65 aa)
Fragment:UNP Residues 27-91
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;303.15 K;10% (v/v) 2-propanol, 0.1M HEPES pH 7.5, 0.2M NaCl
|
Resolution 5.50 Å R-free 0.286 |
| 6FGP NMR solution structure of monomeric CCL5 in complex with a doubly-sulfated N-terminal segment of CCR5 Deposited 2018-01-11 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
24–91(68 aa)
|
Mutation:i | No recorded non-water small molecule |
SOLUTION NMR
NMR measurement conditions
pH 4.8;310 K;Ionic strength (raw mmCIF value) 130;Pressure 1
NMR measurement conditions
pH 4.8;310 K;Ionic strength (raw mmCIF value) 130;Pressure 1
NMR measurement conditions
pH 4.8;310 K;Ionic strength (raw mmCIF value) 130;Pressure 1
NMR sample composition
120 uM [U-15N] CCL5(P9S)/Nt-CCR5(1-27), 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
120 uM [U-13C] CCL5(P9S)/Nt-CCR5(1-27), 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
120 uM U-15N;13C CCL5(P9S)/Nt-CCR5(1-27), 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided |
| 6LOG Crystal structure of human CCL5-12AAA14 mutant Deposited 2020-01-05 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
|
Mutation:F12A, Y14A | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.9;283 K;0.2M Magnesium acetate tetrahydrate pH 7.9, 20% PEG 3350
|
Resolution 2.55 Å R-free 0.249 |
| 6STK Crystal structure of the CC-chemokine 5 (CCL5) E66S mutation Deposited 2019-09-10 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
24–91(68 aa)
Chain B
24–91(68 aa)
|
Mutation:E66S Mutation:E66S | ACT ACETATE ION × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;15% glycerol, 25.5% PEG 4000, 85mM acetate buffer pH 4.6, 0.17 M ammonium acetate
|
Resolution 1.52 Å R-free 0.203 |
| 7F1R Cryo-EM structure of the chemokine receptor CCR5 in complex with RANTES and Gi Deposited 2021-06-09 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain R
24–91(68 aa)
|
Mutation:F28C,G258N,E267C | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å |
| 7O7F Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist Deposited 2021-04-13 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 7 PDB declaration: heptameric |
Chain I
23–91(69 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.15 Å |
22 other PDB entries and 25 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | CCL5_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–65; UniProt 27–91 Author chain B; PDBConstruct 1–65; UniProt 27–91 Author chain C; PDBConstruct 1–65; UniProt 27–91 Author chain D; PDBConstruct 1–65; UniProt 27–91 Author chain E; PDBConstruct 1–65; UniProt 27–91 Author chain F; PDBConstruct 1–65; UniProt 27–91 |